Guardant Health, Inc. (GH) Institutional Ownership

Ownership Summary

Guardant Health, Inc. (NASDAQ:GH) has 484 institutional investors with active 13F positions as of December 2025.

• Their combined ownership stood at 102.4% of outstanding shares in December 2025, up from 99.7% in September 2025.
• They increased total shares held in Guardant Health by 8.54% from the prior quarter, while the number of investors in GH increased 64.07% year over year.
• Among the 484 funds, 285 bought more Guardant Health shares, 148 sold down, and 51 held their ground.
• Altogether, these fund groups held 127.86Mn shares in GH by December 2025, up by 10.06Mn shares quarter on quarter, and up 4.88Mn shares year over year.
• As of December 31, 2025, BlackRock, Inc. held the largest stake in Guardant Health with 11.55Mn shares, accounting for 9.26% of total shares outstanding.
• Leading buyers of Guardant Health shares for the quarter ending December 2025 were PRICE T ROWE ASSOCIATES INC /MD/ (7.02Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (5.84Mn), VANGUARD CAPITAL MANAGEMENT LLC (5.62Mn), TWO SIGMA INVESTMENTS, LP (2.06Mn), PIER 88 INVESTMENT PARTNERS LLC (2.05Mn).
• Leading sellers of Guardant Health shares for the quarter ending December 2025 were FULLER & THALER ASSET MANAGEMENT, INC. (2.33Mn), BAILLIE GIFFORD & CO (1.03Mn), JENNISON ASSOCIATES LLC (966.56K), Goldman Sachs Group Inc (819.44K), Point72 Asset Management, L.P. (803.23K).
• Business Quant data shows the 10 biggest positions in Guardant Health as of December 2025 are held by BlackRock, Inc. (11.55Mn), PRICE T ROWE ASSOCIATES INC /MD/ (7.02Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (5.84Mn), VANGUARD CAPITAL MANAGEMENT LLC (5.62Mn), Invesco Ltd. (4.95Mn), Goldman Sachs Group Inc (4.44Mn), TWO SIGMA INVESTMENTS, LP (4.23Mn), FMR LLC (4.12Mn), BAILLIE GIFFORD & CO (3.86Mn), GEODE CAPITAL MANAGEMENT, LLC (3.51Mn).